Clinical Trials
8 trialsNCT05485831 2026-06-03
EpiTALY
Jazz Pharmaceuticals
Active not recruiting
NCT05044819 2026-06-01
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Jazz Pharmaceuticals
Phase 4 Active not recruiting
NCT02962414 2026-04-02
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Novartis
Phase 3 Active not recruiting
NCT05252585 2026-04-02
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
Novartis
Phase 4 Active not recruiting
NCT06392009 2026-04-01
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
GRIN Therapeutics, Inc.
Phase 1/2 Active not recruiting
NCT05467397 2026-01-21
Feasibility of [11C]Acetate-PET in LAM and TSC
Brigham and Women's Hospital
Phase 1/2 Active not recruiting
NCT04198181 2025-01-17
The Effectiveness and Safety of Resective Epilepsy Surgery for TRE
Beijing Children's Hospital
Active not recruiting
NCT02461459 2024-10-26
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Boston Children's Hospital
Active not recruiting